Zevalin and BEAM (Z-BEAM) versus rituximab and BEAM (R-BEAM) conditioning chemotherapy prior to autologous stem cell transplantation in patients with mantle cell lymphoma.

Berger, M.D., Branger, G., Klaeser, B., Taleghani, B.Mansouri, Novak, U., Banz, Y., Mueller, B.U., and Pabst, T. (2015). Zevalin and BEAM (Z-BEAM) versus rituximab and BEAM (R-BEAM) conditioning chemotherapy prior to autologous stem cell transplantation in patients with mantle cell lymphoma.Hematol Oncol.